RYTVELA TFA

Description: RYTVELA TFA (H-Arg-Tyr-Thr-Val-Glu-Leu-Ala-OH) is a non-competitive metabotropic interleukin-1 receptor inhibitor with anti-inflammatory activity that inhibits upregulation of inflammation and uterine activation, and may be used for the prevention of preterm labor and for fetal protection. Target: IL Receptor. Smiles: [C@H](CC1=CC=C(O)C=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)C)=O)CC(C)C)=O)CCC(O)=O)=O)[C@H](C)C)=O)[C@@H](C)O)=O)NC([C@H](CCCNC(=N)N)N)=O. References: Quiniou C, et al. Development of a novel noncompetitive antagonist of IL-1 receptor. J Immunol. 2008 May 15,180(10):6977-87.